$ATRO

Astronics Corporation (ATRO) Gains 49% YTD, 171% in 1Y

Astronics (ATRO) shares were up 49% year-to-date as of May 22 and 171% over the past 12 months, according to market data cited in the article. The report says Q1 2026 sales rose 12% to $230.6 million, with net income of $0.67 per diluted share. Adjusted EBITDA increased to $37.9 million; order bookings were $290.4 million, lifting backlog to $734.3 million. The company raised full-year revenue guidance to $970 million–$1 billion.

Original reporting
Published May 28, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 28, 2026, 12:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Astronics Corporation (ATRO) Gains 49% YTD, 171% in 1Y — source image
Decision brief

The 30-second read

$ATROBullishMed
01

Why it matters

Q1 2026 strength (sales growth, higher net income per diluted share, higher adjusted EBITDA) plus record backlog and raised full-year revenue guidance are the core catalysts for repricing.

02

Market read

This is a single-name fundamental catalyst (earnings + guidance raise) supporting continued momentum trading in ATRO.

03

What to watch

The article doesn’t quantify margin drivers or customer concentration; any softness in commercial transport demand could pressure future quarters despite a record backlog.

Relevance 9/10Novelty 7/10Timing: post-Q1 earnings/guidance update (published May 28)

Background

The piece frames ATRO as a top-performing defense stock in 2026, attributing momentum to operational improvements and a guidance revision.

Company-level read

Ticker impact

$ATROBullishHigh confidence
Context

Astronics reported Q1 2026 results with higher sales, record backlog, and raised full-year revenue guidance to $970M–$1B.

Expected impact

Near-term upside bias as traders reprice revenue/growth expectations; follow-through depends on whether backlog converts to revenue in coming quarters.

Evidence & confidence

The article cites concrete, decision-relevant datapoints (Q1 print, record backlog, and guidance raise) rather than commentary, which typically drives repricing.

Market effects

Strength in aerospace/defense electronics demand and backlog visibility can lift sentiment for similarly positioned defense suppliers.

Primarily US-listed defense/aerospace sentiment; limited direct regional read-through from the article.

Commercial transport demand strength cited may resonate with global aerospace supply chains.

Counterpoint

Guidance raises can already be partially priced after a strong YTD move; investors may demand proof of backlog-to-revenue conversion.

Key entities

  • Astronics Corporation

    Reported Q1 2026 results, record backlog, and raised full-year revenue guidance.

  • Pertento Partners LLP

    Initiated a position by acquiring 815,333 shares worth about $59M (as reported in the article).

Related articles

$ATROMed

Astronics Corporation Announces Favorable Appeal Ruling on Lufthansa Technik Intellectual Property Case in United Kingdom

Astronics (Nasdaq: ATRO) said a UK appellate court dismissed Lufthansa Technik AG’s appeal of a February 2025 damages ruling in their UK patent infringement case. The court granted one of Astronics’ appeals, requiring a partial refund of previously paid damages, with the amount to be determined, and possible additional attorney-fee amounts. Either party may seek UK Supreme Court review.

$ATROMedAI 8/10

Analysts See 21% Upside To Astronics Corporation (ATRO)

Astronics (ATRO) shares were rated a “Strong Buy” with 21% average upside potential, according to analysts. TD Cowen’s Gautam Khanna raised its price target to $100 from $85 and kept a Buy rating after the U.S. Army awarded Astronics Test Systems an order for TS-4549/T Radio Test Sets. The $44.7 million order covers deliveries over 20 months.

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.